Interstitial and orphan lung disease

Interstitial and orphan lung disease

Awake or intubated surgery in diagnosis of interstitial lung diseases? A prospective study
Francesco Guerrera, Lorena Costardi, Giulio L. Rosboch, Paraskevas Lyberis, Edoardo Ceraolo, Paolo Solidoro, Claudia Filippini, Giulia Verri, Luca Brazzi, Carlo Albera, Enrico Ruffini

ERJ Open Research Jul 2021, 7 (3) 00630-2020; DOI: 10.1183/23120541.00630-2020
Body mass index and in-hospital mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis
Nobuyasu Awano, Taisuke Jo, Hideo Yasunaga, Minoru Inomata, Naoyuki Kuse, Mari Tone, Kojiro Morita, Hiroki Matsui, Kiyohide Fushimi, Takahide Nagase, Takehiro Izumo

ERJ Open Research Apr 2021, 7 (2) 00037-2021; DOI: 10.1183/23120541.00037-2021
Endobronchial autologous bone marrow–mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial
Arantza Campo, José María González-Ruiz, Enrique Andreu, Ana B. Alcaide, María M. Ocón, Juan De-Torres, Jesús Pueyo, Rosa Cordovilla, Eva Villaron, Fermín Sanchez-Guijo, Miguel Barrueco, Jorge Nuñez-Córdoba, Felipe Prósper, Javier J. Zulueta

ERJ Open Research Apr 2021, 7 (2) 00773-2020; DOI: 10.1183/23120541.00773-2020
Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease
Robin Deterding, Matthias Griese, Gail Deutsch, David Warburton, Emily M. DeBoer, Steven Cunningham, Annick Clement, Nicolaus Schwerk, Kevin R. Flaherty, Kevin K. Brown, Florian Voss, Ulrike Schmid, Rozsa Schlenker-Herceg, Daniela Verri, Mihaela Dumistracel, Marilisa Schiwek, Susanne Stowasser, Kay Tetzlaff, Emmanuelle Clerisme-Beaty, Lisa R. Young

ERJ Open Research Apr 2021, 7 (2) 00805-2020; DOI: 10.1183/23120541.00805-2020
Transition of patients with interstitial lung disease from paediatric to adult care
Václav Koucký, Petr Pohunek, Martina Vašáková, Andrew Bush

ERJ Open Research Apr 2021, 7 (2) 00964-2020; DOI: 10.1183/23120541.00964-2020
Spectrum of childhood interstitial and diffuse lung diseases at a tertiary hospital in Egypt
Salma G. Abdelhady, Eman M. Fouda, Malak A. Shaheen, Faten A. Ghazal, Ahmed M. Mostafa, Ahmed M. Osman, Andrew G. Nicholson, Heba M. Hamza

ERJ Open Research Apr 2021, 7 (2) 00880-2020; DOI: 10.1183/23120541.00880-2020
Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis
Evans R. Fernández Pérez, James L. Crooks, Jeffrey J. Swigris, Joshua J. Solomon, Michael P. Mohning, Tristan J. Huie, Matthew Koslow, David A. Lynch, Steve D. Groshong, Kaitlin Fier

ERJ Open Research Apr 2021, 7 (2) 00054-2021; DOI: 10.1183/23120541.00054-2021
Anti-HSP47 siRNA lipid nanoparticle ND-L02-s0201 reverses interstitial pulmonary fibrosis in preclinical rat models
Yun Liu, Jian Liu, Alistair Quimbo, Fengcheng Xia, Jiping Yao, Jean-Pierre Clamme, Sonya Zabludoff, Jun Zhang, Wenbin Ying

ERJ Open Research Apr 2021, 7 (2) 00733-2020; DOI: 10.1183/23120541.00733-2020
Telomere shortening and DNA damage in culprit cells of different types of progressive fibrosing interstitial lung disease
Aernoud A. van Batenburg, Karin M. Kazemier, Matthijs F.M. van Oosterhout, Joanne J. van der Vis, Jan C. Grutters, Roel Goldschmeding, Coline H.M. van Moorsel

ERJ Open Research Apr 2021, 7 (2) 00691-2020; DOI: 10.1183/23120541.00691-2020
Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids
Joshua P. Entrop, Susanna Kullberg, Johan Grunewald, Anders Eklund, Kerstin Brismar, Elizabeth V. Arkema

ERJ Open Research Apr 2021, 7 (2) 00028-2021; DOI: 10.1183/23120541.00028-2021

Main menu

User menu

Search

Interstitial and orphan lung disease

Pages

Contact us